Founded in 1981, HYCOR Biomedical is a global manufacturer and marketer of in vitro diagnostic products. Since its founding, HYCOR has served the allergy diagnostic testing needs of clinical laboratories, hospitals and doctors' offices worldwide. The recently launched NOVEOS™ builds upon 40 years of experience in specific IgE testing, and supplements the Company’s existing line of HYTEC® products. The company is focused on delivering NOVEOS, a new generation of fully-automated allergy system that solves the shortcomings of today's technology, with 1/10th the sample requirement and negligible interference issues. For more information, please visit www.HYCORbiomedical.com.
Location: United States, California, Garden Grove
Employees: 51-200
Total raised: $20M
Founded date: 1981
Investors 1
| Date | Name | Website |
| 18.07.2021 | Linden Cap... | lindenllc.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.01.2021 | - | $20M | - |
Mentions in press and media 1
| Date | Title | Description |
| 07.01.2021 | HYCOR Biomedical Raises $20M to Expand Allergy Testing | HYCOR Biomedical can test whether people are allergic to everything from bees to nuts. But the Garden Grove-based diagnostic company is expanding their research and development capacity into less common areas. Every year, 200,000 Americans ... |